30 . 06 .2022
Press release
Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership
08 . 06 .2022
Press release
Galderma to present new findings from innovative product portfolio at the 2022 VCS Annual Symposium
02 . 06 .2022
Press release
Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea
25 . 04 .2022
Press release
Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®
25 . 03 .2022
Press release
Galderma Launches TWYNEO® Cream, the First Ever Tretinoin and Benzoyl Peroxide Combination to Treat Facial Acne
10 . 03 .2022
Press release
Galderma Launches Breakthrough Innovation With ALASTIN Skincare® HA IMMERSE SERUM®
09 . 03 .2022
Press release
Cetaphil® Champions Sensitive Skin Initiative with an Entire Month of Science-Backed Educational Content
07 . 03 .2022
Press release
Differin® Joins Forces with Expert Digital Voices to Kickstart the Acne Conversation for Its Fifth-Annual Retinoid Education Week
13 . 12 .2021
Press release
Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners
08 . 12 .2021
Press release
Galderma announces relocation of U.S. Headquarters to downtown Dallas